Questa Capital led the funding round, and existing investors also participated. The money will scale all aspects of commercialization including a new product pipeline, sales channel and medical education, according to a news release. Ossio will also build a flagship U.S. manufacturing site and surgeon training in Florida.
Ossiofiber implants provide fixation without metal and bone in-growth, regeneration and replacement.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
